Form 4: Janux Therapeutics Insider Buys Shares
Insider Transaction Report
Janux Therapeutics President and CEO David Alan Campbell acquired 7,000 shares of common stock.
Summary
- David Alan Campbell, President and CEO of Janux Therapeutics, Inc., acquired 7,000 shares of common stock on July 8, 2026.
- The acquisition was made at a price of $4.21 per share.
- Following this transaction, Campbell beneficially owns 388,582 shares of common stock directly.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as insider buying can indicate confidence, but the transaction itself is routine disclosure and doesn't provide new strategic or financial information.
Positives
- Insider buying activity, particularly by a CEO, can signal confidence in the company's future prospects.
- The acquisition of 7,000 shares by the President and CEO indicates a personal investment in the company's stock.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider transactions, such as this Form 4 filing by Janux Therapeutics' CEO, are closely watched by investors as potential indicators of management's confidence in the company's valuation and future performance within the biotechnology sector.
Stakeholder Impact
- Shareholders may view this insider purchase positively, interpreting it as a sign of management's belief in the company's value.
Key Dates
| Date | Description |
|---|---|
| 07/08/2026 | Transaction Date for acquisition of common stock and stock option. |
| 07/10/2026 | Date of signature by reporting person's attorney-in-fact. |
Keywords
Janux Therapeutics, JANX, Form 4, Insider Trading, Stock Acquisition, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.